Sharing mRNA vaccine technology could address COVID and help prepare for future pandemics, as well as open doors to vaccines for HIV, TB and other diseases that impact communities where MSF works. Photo credit: Sandra Calligaro
Newsletter |
28 April 2022

Share vaccine tech! Prepare for the future!

Sharing mRNA vaccine technology could address COVID and help prepare for future pandemics, as well as open doors to vaccines for HIV, TB and other diseases that impact communities where MSF works. Photo credit: Sandra Calligaro

Today at its annual shareholders meeting, Moderna will report billions in profits during the ongoing COVID pandemic. The company has already made US$17.7 billion from vaccine sales in 2021. Despite $10 billion in public taxpayer money that went into Moderna’s development and delivery of the COVID vaccine, Moderna refuses to share the mRNA technology behind the vaccine with the rest of the world. 

Continue Reading